Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

6.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.8K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Another step toward phenotypic characterization of hereditary dysfibrinogenemia?

Research and practice in thrombosis and haemostasis·2026
Same author

Successful Treatment of Heavy Menstrual Bleeding in a Woman With Mild Haemophilia A Using Efanesoctocog Alfa.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

An Unusual Association Between Acquired Hemophilia A and Type 2 Autoimmune Pancreatitis.

Hamostaseologie·2026
Same author

Rare Bleeding Disorders and Bleeding Disorder of Unknown Cause: Current Understanding and Recent Developments.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

The fibrinogen αC region promotes arterial thrombosis in the context of hypofibrinogenemia.

Blood·2026
Same author

Fibrin-bound thrombin determines clot structure and blood thrombogenicity in normofibrinogenemia and dysfibrinogenemia.

Haematologica·2026

相关实验视频

Updated: Sep 10, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.1K

在先天性纤维素缺乏症中的血栓悖论:从病理生理学到实践

Samin Mohsenian1, Alessandro Casini2, Flora Peyvandi1,3

  • 1Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

Research and practice in thrombosis and haemostasis
|August 21, 2025
PubMed
概括

由于纤维素异常,先天性纤维素缺乏症 (CFD) 矛盾地增加了血栓形成的风险. 这需要平衡出血和凝血风险,而治疗指导的证据有限.

关键词:
血红细胞增生症血液凝固疾病遗传性纤维素缺乏这种疾病不适应.纤维素低纤维基因血症低纤维基因血症管理层危险因素血栓友爱症静脉血栓形成

更多相关视频

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.9K
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.6K

相关实验视频

Last Updated: Sep 10, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.1K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.9K
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.6K

科学领域:

  • 血液学
  • 遗传学
  • 血栓形成研究

背景情况:

  • 遗传性纤维素缺乏症 (CFD) 是一种罕见的遗传性疾病,影响纤维素的数量或质量.
  • 虽然通常与出血有关,但CFD越来越多地与动脉和静脉血栓相关.
  • 这些机制包括血栓清除受损,血块结构异常和纤维解衰减.

研究的目的:

  • 审查CFD中血栓形成的流行病学,机制和临床管理.
  • 突出知识缺口和进一步研究的需要.

主要方法:

  • 对先天性纤维素缺乏的血栓形成现有证据的文献综述.
  • 拟议的致病机制的分析,包括内在纤维素变异和外在因素.
  • 讨论当前面临的挑战和治疗血栓形成的方法.

主要成果:

  • CFDs可以通过增加的自由血栓或受损的纤维解质等机制导致血栓形成.
  • 内在因素 (例如特定的纤维素变异) 和外在因素 (例如手术,固定) 都会导致血栓形成的风险.
  • 治疗是复杂的,需要在抗凝药和纤维素替代疗法的潜在风险之间保持平衡.

结论:

  • 在CFD中发生血栓的发病因子是多因素的,并未完全理解.
  • 在CFD中进行血栓形成的临床治疗具有挑战性,需要个性化治疗策略.
  • 进一步的研究对于改善患者的理解和结果至关重要.